254 related articles for article (PubMed ID: 31454708)
1. Improving therapy of severe infections through drug repurposing of synergistic combinations.
Cheng YS; Williamson PR; Zheng W
Curr Opin Pharmacol; 2019 Oct; 48():92-98. PubMed ID: 31454708
[TBL] [Abstract][Full Text] [Related]
2. Drug repurposing screens and synergistic drug-combinations for infectious diseases.
Zheng W; Sun W; Simeonov A
Br J Pharmacol; 2018 Jan; 175(2):181-191. PubMed ID: 28685814
[TBL] [Abstract][Full Text] [Related]
3. Drug Repurposing to Fight Colistin and Carbapenem-Resistant Bacteria.
Peyclit L; Baron SA; Rolain JM
Front Cell Infect Microbiol; 2019; 9():193. PubMed ID: 31245302
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy: the propitious rationale for drug development.
Phougat N; Khatri S; Singh A; Dangi M; Kumar M; Dabur R; Chhillar AK
Comb Chem High Throughput Screen; 2014 Jan; 17(1):53-67. PubMed ID: 24138510
[TBL] [Abstract][Full Text] [Related]
5. Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria.
Liu Y; Tong Z; Shi J; Li R; Upton M; Wang Z
Theranostics; 2021; 11(10):4910-4928. PubMed ID: 33754035
[TBL] [Abstract][Full Text] [Related]
6. Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy.
Ejim L; Farha MA; Falconer SB; Wildenhain J; Coombes BK; Tyers M; Brown ED; Wright GD
Nat Chem Biol; 2011 Jun; 7(6):348-50. PubMed ID: 21516114
[TBL] [Abstract][Full Text] [Related]
7. Repurposing Screen Identifies Unconventional Drugs With Activity Against Multidrug Resistant
Cheng YS; Sun W; Xu M; Shen M; Khraiwesh M; Sciotti RJ; Zheng W
Front Cell Infect Microbiol; 2018; 8():438. PubMed ID: 30662875
[TBL] [Abstract][Full Text] [Related]
8. Recent Drug-Repurposing-Driven Advances in the Discovery of Novel Antibiotics.
Konreddy AK; Rani GU; Lee K; Choi Y
Curr Med Chem; 2019; 26(28):5363-5388. PubMed ID: 29984648
[TBL] [Abstract][Full Text] [Related]
9. Reprogramming of antibiotics to combat antimicrobial resistance.
Dubey KK; Indu ; Sharma M
Arch Pharm (Weinheim); 2020 Nov; 353(11):e2000168. PubMed ID: 32776618
[TBL] [Abstract][Full Text] [Related]
10. Repositioning of non-antibiotic drugs as an alternative to microbial resistance: a systematic review.
Foletto VS; da Rosa TF; Serafin MB; Bottega A; Hörner R
Int J Antimicrob Agents; 2021 Sep; 58(3):106380. PubMed ID: 34166776
[TBL] [Abstract][Full Text] [Related]
11. Synergistic combinations of anthelmintic salicylanilides oxyclozanide, rafoxanide, and closantel with colistin eradicates multidrug-resistant colistin-resistant Gram-negative bacilli.
Domalaon R; Okunnu O; Zhanel GG; Schweizer F
J Antibiot (Tokyo); 2019 Aug; 72(8):605-616. PubMed ID: 31028351
[TBL] [Abstract][Full Text] [Related]
12. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
[TBL] [Abstract][Full Text] [Related]
13. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of MDR pathogens of bacterial meningitis in Egypt and new synergistic antibiotic combinations.
Abdelkader MM; Aboshanab KM; El-Ashry MA; Aboulwafa MM
PLoS One; 2017; 12(2):e0171349. PubMed ID: 28207768
[TBL] [Abstract][Full Text] [Related]
15. Repurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens.
Thangamani S; Younis W; Seleem MN
PLoS One; 2015; 10(7):e0133877. PubMed ID: 26222252
[TBL] [Abstract][Full Text] [Related]
16. [Combination therapy against multidrug-resistant bacteria].
Araoka H
Nihon Rinsho; 2012 Feb; 70(2):305-10. PubMed ID: 22413536
[TBL] [Abstract][Full Text] [Related]
17. Paradigm Shift in Drug Re-purposing From Phenalenone to Phenaleno-Furanone to Combat Multi-Drug Resistant
Mujawar S; Gatherer D; Lahiri C
Front Cell Infect Microbiol; 2018; 8():402. PubMed ID: 30488026
[TBL] [Abstract][Full Text] [Related]
18. Repurposing auranofin for the treatment of cutaneous staphylococcal infections.
Thangamani S; Mohammad H; Abushahba MF; Sobreira TJ; Seleem MN
Int J Antimicrob Agents; 2016 Mar; 47(3):195-201. PubMed ID: 26895605
[TBL] [Abstract][Full Text] [Related]
19. Combination approaches to combat multidrug-resistant bacteria.
Worthington RJ; Melander C
Trends Biotechnol; 2013 Mar; 31(3):177-84. PubMed ID: 23333434
[TBL] [Abstract][Full Text] [Related]
20. Investigational drugs for the treatment of infections caused by multidrug-resistant Gram-negative bacteria.
Avery LM; Nicolau DP
Expert Opin Investig Drugs; 2018 Apr; 27(4):325-338. PubMed ID: 29611447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
